Search clinical trials for: Triple negative breast cancer (TNBC)
Total 92694 results
-
Ayala Pharmaceuticals, Inc,TerminatedTriple Negative Breast CancerUnited States, Belgium, Israel, Spain, United Kingdom
-
Xijing HospitalRoche Pharma AGUnknownBreast Cancer | Triple Negative Breast Cancer | CapecitabineChina
-
Universidad Nacional de ColombiaFundación Salud de los AndesNot yet recruiting
-
ImmunityBio, Inc.WithdrawnTriple Negative Breast Cancer (TNBC)United States
-
Laekna LimitedCompletedSolid Tumor | TNBC - Triple-Negative Breast CancerChina
-
Marker Therapeutics, Inc.CompletedBreast CancerUnited States
-
PIQUR Therapeutics AGHospital Universitari Vall d'Hebron Research Institute; Institut Català d'Oncologia and other collaboratorsCompletedMetastatic Breast CancerSpain, United Kingdom
-
Palleos Healthcare GmbHRoche Pharma AG; University Hospital, Essen; University Hospital Erlangen; Phaon...Active, not recruitingTriple-negative Breast CancerGermany
-
Huihua XiongNot yet recruitingMetastatic Triple-negative Breast CancerChina
-
Priyanka SharmaBristol-Myers Squibb; Celgene CorporationActive, not recruitingBreast Cancer | Triple-Negative Breast CancerUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedInvasive Breast Carcinoma | Triple-Negative Breast Carcinoma | Stage I Breast Cancer AJCC v7 | Stage IA Breast Cancer AJCC v7 | Stage IB Breast Cancer AJCC v7 | Stage II Breast Cancer AJCC v6 and v7 | Stage IIA Breast Cancer AJCC v6 and v7 | Stage IIB Breast Cancer AJCC v6 and v7 | Stage III Breast... and other conditionsUnited States
-
Vastra Gotaland RegionLund University; Sahlgrenska University Hospital, SwedenNot yet recruitingBreast Cancer | Triple Negative Breast CancerSweden
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.Recruiting
-
Curis, Inc.CompletedHigh-grade Serous Ovarian Cancer | Solid Tumors | Triple-Negative Breast Cancer | NUT Midline CarcinomaUnited States
-
Antonio Giordano, MDCardiff OncologyRecruitingBreast Cancer | Metastatic Breast Cancer | Inflammatory Breast Cancer | Invasive Breast Cancer | Locally Advanced Breast Cancer | Unresectable Breast Carcinoma | HER2-negative Breast Cancer | Triple Negative Breast Cancer (TNBC) | Hormone Receptor Negative Breast Carcinoma | Hormone Receptor/Growth Factor...United States
-
Genexine, Inc.Merck Sharp & Dohme LLCCompletedTriple Negative Breast CancerKorea, Republic of
-
OncoSec Medical IncorporatedCompletedER-Negative PR-Negative HER2-Negative Breast CancerUnited States
-
Fudan UniversityUnknown
-
BioLite, Inc.Not yet recruiting
-
BerGenBio ASAMerck Sharp & Dohme LLCTerminatedTriple Negative Breast Cancer | Inflammatory Breast Cancer Stage IVSpain, United States, United Kingdom, Norway
-
Novartis PharmaceuticalsCompletedAdvanced Triple Negative Breast Cancer (TNBC) With High TAMsFrance, Italy, Austria, Taiwan, United States, Spain, Australia, Korea, Republic of, Belgium, Germany, Hong Kong, Turkey
-
Fudan UniversityRecruiting
-
Fudan UniversityCompleted
-
Massachusetts General HospitalGilead SciencesRecruitingTriple Negative Breast Cancer | Invasive Breast Cancer | HER2-negative Breast Cancer | ER-Negative Breast Cancer | PR-Negative Breast CancerUnited States
-
G1 Therapeutics, Inc.Active, not recruitingTriple Negative Breast CancerUnited States
-
Fudan UniversityZhejiang Cancer Hospital; Changhai Hospital; 307 Hospital of PLA; Sun Yat-sen University and other collaboratorsCompleted
-
Cancer Institute and Hospital, Chinese Academy...Beijing Huanxing Cancer Hospital; Cancer Hospital, Chinese Academy of Medical...RecruitingEarly-stage Breast CancerChina
-
Fudan UniversityActive, not recruitingTriple Negative Breast CancerChina
-
CytoDyn, Inc.Amarex Clinical ResearchActive, not recruitingTriple Negative Breast NeoplasmsUnited States
-
MedSIRGilead SciencesActive, not recruitingBreast Cancer | Triple Negative Breast CancerSpain
-
Dana-Farber Cancer InstituteWithdrawnBreast Cancer | Breast Neoplasms | Breast Carcinoma | Triple Negative Breast Cancer | Breast Cancer Stage II | Breast Cancer Stage III | Early Stage Triple-Negative Breast CarcinomaUnited States
-
NSABP Foundation IncHoffmann-La Roche; Genentech, Inc.Active, not recruitingTriple Negative Breast CancerUnited States, Canada
-
Fudan UniversityRecruiting
-
Fudan UniversityRecruiting
-
Beijing 302 HospitalRecruitingTNBC - Triple-Negative Breast CancerChina
-
Dana-Farber Cancer InstituteMerck Sharp & Dohme LLC; Gilead SciencesRecruitingBreast Cancer | Triple Negative Breast Cancer | PD-L1 NegativeUnited States
-
Kari WisinskiNovartis; University of Wisconsin, Madison; Big Ten Cancer Research ConsortiumRecruiting
-
AHS Cancer Control AlbertaNot yet recruitingBreast Cancer Triple NegativeCanada
-
Anqin ZhangNot yet recruiting
-
Hebei Medical University Fourth HospitalWithdrawnTriple Negative Breast CancerChina
-
Columbia UniversityWyeth is now a wholly owned subsidiary of Pfizer; Genentech, Inc.CompletedTriple Negative Breast CancerUnited States
-
Guangdong Provincial People's HospitalRecruitingTriple Negative Breast CancerChina
-
Henan Cancer HospitalUnknownTriple-negative Breast Cancer
-
Severance HospitalUnknown
-
Fudan UniversityRecruitingTriple-Negative Breast CancerChina
-
Peking Union Medical College HospitalUnknownFemale Breast CancerChina
-
The First Affiliated Hospital with Nanjing Medical...Jiangsu HengRui Medicine Co., Ltd.RecruitingTNBC - Triple-Negative Breast CancerChina
-
Stephen ShiaoMerck Sharp & Dohme LLC; Incyte CorporationRecruitingBreast Cancer | TNBC - Triple-Negative Breast CancerUnited States
-
Mario Negri Institute for Pharmacological ResearchTerminatedTriple Negative Breast CancerSpain, Italy, Portugal